Effect of Sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes

Medicin og biovidenskab

• Sitagliptin Phosphate 100%
• Lipoproteins 66%
• Type 2 Diabetes Mellitus 52%
• Incretins 39%
• Area Under Curve 32%
• Glucose 25%
• Triglycerides 24%
• Hormones 21%
• Nonesterified Fatty Acids 20%
• Insulin Resistance 16%
• Apolipoprotein B-48 15%
• Homeostasis 14%
• Dipeptidyl-Peptidase IV Inhibitors 13%
• VLDL Cholesterol 13%
• Lipids 13%
• Glucagon-Like Peptide 1 11%
• C-Peptide 11%
• Therapeutics 11%
• Body Surface Area 11%
• Apolipoproteins B 11%
• Glucagon 10%
• Liver 10%
• Cross-Over Studies 9%
• Fasting 8%
• Fats 7%
• Body Mass Index 7%
• Placebos 6%
• Insulin 6%
• Peptides 6%